Trinity Biotech PLC
NASDAQ:TRIB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Trinity Biotech PLC
Deferred Income Tax
Trinity Biotech PLC
Deferred Income Tax Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Deferred Income Tax | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Trinity Biotech PLC
NASDAQ:TRIB
|
Deferred Income Tax
$4.6m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-15%
|
|
|
Medtronic PLC
NYSE:MDT
|
Deferred Income Tax
$365m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-21%
|
|
|
STERIS plc
NYSE:STE
|
Deferred Income Tax
$414.5m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
9%
|
CAGR 10-Years
4%
|
|
Trinity Biotech PLC
Glance View
Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. The company is headquartered in Bray, Wicklow. The firm's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. The company operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business.
See Also
What is Trinity Biotech PLC's Deferred Income Tax?
Deferred Income Tax
4.6m
USD
Based on the financial report for Sep 30, 2025, Trinity Biotech PLC's Deferred Income Tax amounts to 4.6m USD.
What is Trinity Biotech PLC's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 10Y
-15%
Over the last year, the Deferred Income Tax growth was 129%. The average annual Deferred Income Tax growth rates for Trinity Biotech PLC have been -5% over the past three years , -6% over the past five years , and -15% over the past ten years .
